Earnings Call · Q4 FY2022·2023-02-08

Q4 22EPS +3.11%·Rev n/aQ3 22EPS +8.04%·Rev n/aQ2 22EPS +10.09%·Rev n/aQ1 22EPS +3.26%·Rev n/a⚠ consensus missing

CVS HEALTH Corp CVS

Tom Cowhey — Senior Vice President of Capital Markets

Karen Lynch — President and Chief Executive Officer

Mike Pykosz — Chairman, CEO and Co-Founder

Shawn Guertin — Executive Vice President and Chief Financial Officer

+3.5%1d on move date+4.6% vs SPY3d+4.3%5d+3.0%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CVS calls or request research access.

More CVS calls Browse calls Request research access